Davide Roccarina

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Pulmonary Arterial Hypertension

High Fat Diet Induced

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Davide Roccarina, Giovanna Ferraioli
Editorial: ARFI-based techniques are better than VCTE for diagnosing advanced fibrosis in severe obesity. Alimentary pharmacology & therapeutics 60 (2) (2024)
Davide Roccarina, Giovanna Ferraioli
Editorial: ARFI-based techniques are better than VCTE for diagnosing advanced fibrosis in severe obesity. Alimentary pharmacology & therapeutics 60 (2) (2024)
Davide Roccarina, Giovanna Ferraioli
Editorial: ARFI-based techniques are better than VCTE for diagnosing advanced fibrosis in severe obesity. Alimentary pharmacology & therapeutics (2024)
Davide Roccarina, Laura Iogna Prat, Giada Pallini, Marta Guerrero Misas, Elena Buzzetti, Francesca Saffioti, Francesco M Aricò, Anna Mantovani, Evangelia Koutli, Atul Goyale, Matteo Rosselli, Tu Vinh Luong, Massimo Pinzani, Emmanuel A Tsochatzis
Comparison of point-shear wave elastography (ElastPQ) and transient elastography (FibroScan) for liver fibrosis staging in patients with non-alcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver 42 (10) (2022)
Amine Benmassaoud, Davide Roccarina, Francesco Marcello Arico, Cilla Marta, Rossella Donghia, Gioacchino Leandro, Laura Iogna Prat, Mohamed Zuhair, Matthew North, Orla Kearney, John Ryan, Emmanuel A Tsochatzis
Sex is a major effect modifier between body composition and mortality in patients with cirrhosis assessed for liver transplantation. Liver international : official journal of the International Association for the Study of the Liver (2022)
Silvia Aspite, Filippo Schepis, Davide Roccarina, Stefano Gitto, Michele Citone, Chiara Di Bonaventura, Marcello Bianchini, Umberto Arena, Alessandro M Vannucchi, Paola Guglielmelli, Francesca Campani, Fabrizio Fanelli, Fabio Marra, Francesco Vizzutti
Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status. Liver international : official journal of the International Association for the Study of the Liver 42 (2) (2022)